Literature DB >> 16354880

Concurrent robotic hybrid revascularization using an enhanced operative suite.

Bob Kiaii1, R Scott McClure, William J Kostuk, Reiza Rayman, Stuart Swinamer, Wojciech B Dobkowski, Richard J Novick.   

Abstract

Hybrid myocardial revascularization combines coronary surgery with percutaneous intervention as an alternative therapy for ischemic heart disease. The order and sequence of the hybrid approach is not yet clearly defined. We report on the benefits of an enhanced surgical suite equipped with a carbon fiber operating table and digital C-arm for robotic-assisted hybrid revascularization in a single operative sequence. To our knowledge, this is the first reported case of concurrent robotic-assisted hybrid revascularization utilizing an enhanced operative suite.

Entities:  

Mesh:

Year:  2005        PMID: 16354880     DOI: 10.1378/chest.128.6.4046

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Hybrid theatres: nicety or necessity?

Authors:  Mark L Field; John Sammut; Manoj Kuduvalli; Aung Oo; Abbas Rashid
Journal:  J R Soc Med       Date:  2009-03       Impact factor: 5.344

2.  Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes.

Authors:  Barry Reicher; Robert S Poston; Mandeep R Mehra; Ashish Joshi; Patrick Odonkor; Zachary Kon; Peter A Reyes; David A Zimrin
Journal:  Am Heart J       Date:  2008-03-05       Impact factor: 4.749

Review 3.  Combining PCI and CABG: the role of hybrid revascularization.

Authors:  Kelly D Green; Donald R Lynch; Tyffany P Chen; David Zhao
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

4.  Angiography suite concept for an interdisciplinary centre for cardiovascular interventions.

Authors:  Ulf K M Teichgräber; Christian Wintzer; Bernd Hamm
Journal:  Insights Imaging       Date:  2010-07-29

5.  [Not Available].

Authors:  Ahmed A Alsaddique
Journal:  Open Cardiovasc Med J       Date:  2009-04-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.